Corcept Therapeutics Inc
CORT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001088856
In the last 90 days, Corcept Therapeutics Inc insiders filed 0 open-market purchases and 21 sales; 424 institutions reported holding it in 13F filings for Q2 2026, worth $7.15B in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Corcept Therapeutics Inc changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 233 | 225 | −8 |
| Shares | 86.8M | 81.5M | −5.33M (−6.1%) |
| Value | $1.89B | $1.81B | −$80.8M (−4.3%) |
New holders (26)
Institutions that held Corcept Therapeutics Inc at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (34)
Institutions that held Corcept Therapeutics Inc at the end of Q1 2023 and filed for Q2 2023 without it.